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Abstract
Infectious bursal disease virus (IBDV) belongs to the family Birnaviridae and is economically important to the poultry industry
worldwide. IBDV infects B cells in the bursa of Fabricius (BF), causing immunosuppression and morbidity in young chickens.
In addition to strains that cause classical Gumboro disease, the so-called ‘very virulent’ (vv) strain, also in circulation, causes
more severe disease and increased mortality. IBDV has traditionally been controlled through the use of live attenuated
vaccines, with attenuation resulting from serial passage in non-lymphoid cells. However, the factors that contribute to the vv
or attenuated phenotypes are poorly understood. In order to address this, we aimed to investigate host cell–IBDV interactions
using a recently described chicken primary B-cell model, where chicken B cells are harvested from the BF and cultured ex
vivo in the presence of chicken CD40L. We demonstrated that these cells could support the replication of IBDV when infected
ex vivo in the laboratory. Furthermore, we evaluated the gene expression profiles of B cells infected with an attenuated strain
(D78) and a very virulent strain (UK661) by microarray. We found that key genes involved in B-cell activation and signalling
(TNFSF13B, CD72 and GRAP) were down-regulated following infection relative to mock, which we speculate could contribute
to IBDV-mediated immunosuppression. Moreover, cells responded to infection by expressing antiviral type I IFNs and IFN-
stimulated genes, but the induction was far less pronounced upon infection with UK661, which we speculate could contribute
to its virulence.
INTRODUCTION
Given the expanding human population, set to reach
9.15 billion by 2050 [1] the global poultry industry is essen-
tial to securing enough food for the future. However, immu-
nosuppression has a significant negative impact on the
performance of birds [2] and consequently represents a key
economic challenge, and a threat to global food security.
While environmental stressors and poor nutrition contrib-
ute to immunosuppression, many cases in chickens are
caused by infection with immunosuppressive viruses – for
example, infectious bursal disease virus (IBDV) [2].
IBDV is a highly contagious member of the Birnaviridae
family that commonly ranks among the top five infectious
problems of poultry [3]. The virus causes an acute disease in
chickens known as infectious bursal, or Gumboro, disease
[4, 5]. Infected birds typically display clinical signs such as
ruffled feathers and pale comb/wattles, and they may fail to
gain weight. In more severe cases, birds may lack normal
social interaction and can be observed with half-shut eyes
and drooping wings, as well as signs of weight loss and diar-
rhoea. In the most severe cases, birds may be solitary and
depressed, showing no attempts to feed, and they may have
a crop that is filled with water and vent feathers soiled with
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white faecal material. The virus has a preferred tropism for
B cells, the majority of which are located in the bursa of
Fabricius (BF), and infection leads to B-cell depletion. As a
result, birds that survive the infection are typically immuno-
suppressed, respond less well to vaccination and are more
susceptible to secondary infections, some of which are zoo-
notic and of public health importance. The economic
impact of IBDV is therefore two-fold: first, due to losses
associated with morbidity and mortality and second,
through indirect losses due to immunosuppression [5].
Improving the control of immunosuppressive viruses is a
priority for the poultry industry, and vaccination is the cor-
nerstone of IBDV control. The use of both inactivated and
live attenuated vaccines has been widespread since soon
after the identification of IBDV in the 1960s. Next-genera-
tion vaccines have also been licensed, based on a recombi-
nant herpesvirus of turkey (HVT) vector, or immune
complex vaccines [6]. However, despite these control
efforts, the infection remains endemic worldwide and new
strains have emerged and spread – for example, immune
escape antigenic variants [7, 8] and a pathotypic variant of
the very virulent (vv) phenotype [9, 10], the latter causing
increased severity of disease and higher mortality which can
be up to 60% in some flocks, compared to 1–2% following
infection with classical strains [5].
The chicken B cell is pivotal to the pathogenesis of IBDV. It is
therefore crucial to characterize chicken B-cell–virus interac-
tions, in order to improve our current understanding of viral
pathogenesis and identify areas that can be exploited to
develop novel strategies for controlling IBDV. Key questions
that remain unanswered are the basis for the increased patho-
genicity of the vv strain and the mechanism of attenuation of
cell culture-adapted strains. However, until recently it has not
been possible to culture chicken primary B cells ex vivo
because, when they are removed from the BF, they do not
survive for long [11]. Consequently, it has not been possible
to perform a thorough analysis of the interactions of chicken
B cells with different strains of IBDV, and many pathogenesis
studies to date have been conducted in vivo, where birds are
infected and bursal tissues are harvested at necropsy for
downstream analysis of gene expression [12–17].
The gene encoding chicken CD40 ligand (chCD40L), a mol-
ecule responsible for B-cell proliferation in vivo, was identi-
fied [18] and a soluble fusion protein containing its
extracellular domain was subsequently shown to support
the proliferation of chicken B cells in culture for up to three
weeks [19]. In 2015, Schermuly et al. showed that
chCD40L-treated B cells could be infected with Marek’s dis-
ease virus [11], demonstrating that the cells have the poten-
tial for use in the study of the consequences of
lymphotropic virus infection. Here we report the successful
culture of chicken primary B cells ex vivo in the presence of
soluble chCD40L, and provide data demonstrating that
these cells can support the replication of an attenuated
cell culture-adapted strain of IBDV (D78) and a very viru-
lent strain that does not replicate in non-lymphoid cells
(UK661). Furthermore, we characterize the gene expression
profile of B cells infected with both strains of virus, identify-
ing differences that correlate with pathogenicity.
RESULTS
Chicken primary B cells can be cultured in the
presence of chicken CD40L
Consistent with previous reports [11, 19], we found that
when chicken primary B cells were cultured in the presence
of soluble chCD40L, the number and viability of the cells
was significantly increased compared to when cells were cul-
tured in the absence of chCD40L (Fig. 1). The number of
cells increased 4-fold from 9.02105 to 3.63106 per ml
over a period of 6 days when chCD40L was added to the
culture media, in contrast to when it was absent (*P<0.05)
(Fig. 1a). Cell viability was also significantly improved – for
example, from 25% at day 3 post-culture in the absence of
chCD40L to 48% in its presence (*P<0.05) (Fig. 1b).
Chicken primary B cells can support the replication
of both cell culture-adapted and very virulent
strains of IBDV
At 18 h post-infection, samples of mock and infected cell
cultures were fixed, labelled with a mouse monoclonal anti-
body against IBDV VP2 and a goat anti-mouse secondary
antibody labelled with Alexa Fluor 488, and counterstained
with DAPI. Some cells showed evidence of green fluores-
cence around the nucleus (Fig. 2a), consistent with the pres-
ence of IBDV in the cytoplasm of infected cells. This was
evident for both D78 and UK661 (Fig. 2a). RNA was
extracted from infected cultures at 5, 18, 24 and 48 h p.i.,
and subjected to reverse transcription quantitative polymer-
ase chain reaction (RTqPCR) with primers specific to a con-
served region of IBDV genome segment A encoding the
VP4 gene. The average fold change in Segment A vRNA
increased to 16 603 at 48 h p.i. with D78, and 38 632 at 48 h
p.i. with UK661. At 5 and 18 h p.i., D78 vRNA was signifi-
cantly greater than UK661 (***P<0.001 and *P<0.05 respec-
tively), but no significant difference was detected between
the two strains at 24 or 48 h p.i. (Fig. 2b). Taken together,
these data demonstrate that the chicken primary B cells
could support the replication of cell culture-adapted and vv
IBDV strains. This is in contrast to primary chicken embryo
fibroblasts (CEFs) or the immortalized chicken fibroblast
cell line, DF-1, which do not support the replication of vv
IBDV without prior adaptation that can lead to viral attenu-
ation [20].
Chicken primary B cells infected with vv UK661
and attenuated D78 show a differential gene
expression profile
Next, we aimed to evaluate how the primary B cells
responded to infection with either D78 or UK661. At 5, 18,
24 and 48 h p.i., we determined the level of expression of
type I IFN (IFNb) and the interferon-stimulated gene
(ISG) IFIT5 by RTqPCR. The cells infected with D78
expressed significantly more IFNb and IFIT5 than those
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infected with UK661 at 18, 24 and 48 h p.i. (***P<0.001,
****P<0.0001) (Fig. 3). Moreover, at 24 and 48 h p.i., the
average expression of IFNb in cells infected with UK661
was actually reduced relative to mock-infected cells,
(*P<0.05) (Fig. 3a).
To acquire a broader understanding of the effect of infec-
tion on the transcriptome, gene expression of mock-, D78-
and UK661-infected cultures was screened at 18 h p.i. using
the Affymetrix Chicken Genome array. This array contains
comprehensive coverage of 32 773 transcripts correspond-
ing to over 28 000 chicken genes, and also includes probe
sets for detecting IBDV transcripts, which we used to con-
firm the virus infection. Full raw and processed microarray
data have been deposited in ArrayExpress with the Acces-
sion Number E-MTAB-5947. Principal-component analysis
(PCA) was used to visualize three-dimensional expression
patterns of the RNA data sets (Fig. S1, available in the
online version of this article). The samples for each individ-
ual treatment (mock-, D78-, and UK661-infected samples)
mapped near to each other in a cluster, reflecting minor
variations within replicates of each treatment. However, the
groups were mapped separately to one another, demon-
strating their transcriptomic distinctiveness from one
another.
Analysis of the array data showed that 69 genes were differ-
entially regulated, relative to mock-infected cells, following
D78 infection (P<0.05, fold change cut-off: 1.5), 12 of which
were also those differentially regulated following infection
with UK661 (Fig. 4a). Of the 69 genes differentially regu-
lated following D78 infection, 53 were up-regulated and 16
were down-regulated. In contrast, all 12 genes differentially
Fig. 1. Chicken primary B cells can be cultured in the presence of chicken CD40L. Chicken primary B cells were cultured in the pres-
ence (black bars) or absence (white bars) of chicken (ch)CD40L, and the number of live cells (a) and the percentage of viable cells (b)
were determined at the indicated time-points p.i. Data shown are representative of at least three replicate experiments, error bars
represent the standard deviation of the mean and statistical significance was determined using a two-tailed unpaired Student’s t-test
at each time point; *P<0.05.
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regulated following UK661 infection were up-regulated;
there were no statistically significant down-regulated genes.
A direct comparison of gene expression between D78- and
UK661-infected samples (Table S4) identified 37 differen-
tially regulated genes, 27 of which were up-regulated by
D78, relative to UK661 infection, and 10 of which were
down-regulated. Two of the D78 versus UK661 up-regu-
lated genes (HBG2 and HSP25), and two of the down-
regulated genes (LOC422305 and MCOLN2) were not iden-
tified by the comparisons to mock-infected cells.
Unsupervized hierarchical clustering analysis of the signifi-
cantly differentially regulated genes of the study confirmed
that more transcripts were up-regulated following D78-
infection compared to UK661 infection (Fig. 4b). All the
genes could be divided broadly into four similarly sized
groups: the first group included the 16 genes that were
Fig. 2. Chicken primary B cells can support the replication of both cell culture-adapted and very virulent strains of IBDV. Chicken pri-
mary B cells were mock-infected or infected with either D78 or UK661 and a sample from each culture was fixed, labelled and imaged:
IBDV VP2, green; nuclei, blue; scale bar, 7 µm (a). RNA was extracted at the indicated time-points p.i., reverse transcribed and a con-
served region of IBDV genome segment A (corresponding to the VP4 gene) was amplified by quantitative PCR (b). The Segment A
vRNA Ct values were normalized to the Ct values of the TBP housekeeping gene as per the 2–DCt method and subsequently passed a
Shapiro–Wilk normality test before being analysed using 2-way ANOVA and a Tukey’s multiple comparison test (ns, not significant;
*P<0.05, ***P<0.001). Data were then expressed as log10-fold change in Segment A vRNA relative to mock-infected samples as per the
2–DDCT method. Data shown are representative of at least three replicate experiments, and error bars represent the standard deviation
of the mean.
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transcribed at lower levels in D78-infected samples com-
pared to mock-infected samples. These genes were involved
in B-cell activation and signalling (TNFSF13B, which enco-
des BAFF, CD72, GRAP), immune processes (TLR1LA,
DUSP14, PLD4, MDK, PMP2, F10, GSN) and other pro-
cesses such as protein ubiquitination (UBE2E1) and choles-
terol transport and binding (TSPO2). In addition,
LOC422305 and MCOLN2, found to be significantly down-
regulated in cells infected with D78 relative to those infected
with UK661, were also included in this group, making a total
of 18 genes. The LOC422305 gene encodes the mitochon-
drial-like ES1 protein [21], and the MCOLN2 gene encodes
the ion channel TRPML2 [22] that has been reported to
enhance the replication of yellow fever and dengue viruses
[23, 24]. The other three groups comprised the 53 genes that
were transcribed to a higher level in D78-infected cells
Fig. 3. The expression of IFNb and IFIT5 is significantly up-regulated in chicken primary B cells infected with D78 compared to those
infected with UK661. RNA was extracted from mock-, D78- and UK661-infected cultures at the indicated time points p.i., reverse tran-
scribed and the chicken IFNb (a) and IFIT5 (b) genes were amplified by quantitative PCR. The IFNb and IFIT5 Ct values were normalized
to the Ct values of a housekeeping gene as per the 2–DCt method and passed a Shapiro–Wilk normality test before being analysed
using 2-way ANOVA and Tukey’s multiple comparison test (ns, not significant; *P<0.05, ***P<0.001, ****P<0.0001). Data were then
expressed as fold change in IFNb and IFIT5 RNA relative to mock-infected samples as per the 2–DDCT method. Error bars represent the
standard deviation of the mean.
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relative to mock-infected cells, as well as the two genes that
were significantly up-regulated by infection with D78 rela-
tive to infection with UK661 (HBG2 and HSP25), making a
total of 55 genes. These were further sub-grouped on the
basis of their expression in cells infected with UK661, with
their transcripts being present at: a similar level (19 genes), a
marginally higher level (17 genes) or a moderately higher
level (19 genes) than in mock-infected cells. Most of the
genes in these groups were involved in innate immune
responses (IFI6, SAMD9L, NMI, IRF7, LGP2, IFI35,
HMOX1, LY96, SOCS1 and others), antiviral responses
(OASL, Mx1, IFIT5, RSAD2, IFIH1, IRF1, EIF2AK2 or
Fig. 4. Chicken primary B cells infected with UK661 and D78 have a differential gene expression profile by microarray. RNA was
extracted from mock-, D78- and UK661- infected cultures at 18 h p.i., and subject to microarray analysis. (a) Venn diagram showing
the overlap of differentially expressed genes by D78 and UK661 relative to mock-infected cultures. (b) Hierarchical Clustering heat
map of 73 transcripts that were found to be significantly regulated in at least one of the study’s microarray gene expression compari-
sons using Partek v6.6 software: D78 Vs Mock (blue), UK661 Vs Mock (orange) and D78 Vs UK661 (grey). Each column represents a
sample, and each row represents mRNA quantification of the indicated transcript. The default settings of Euclidian dissimilarity were
used for each row (log2-transformed and median-centred transcripts). The colours correspond to expression intensity values as indi-
cated by the vertical legend (red, up-regulated; dark blue, down-regulated). (c) Distribution histogram of GO process term enrichment
analysis using the MetaCore enrichment analysis tool. The 10 most enriched GO process terms in the microarray comparisons D78
(blue) and UK661 (orange) were plotted relative to mock, as sorted by ‘statistically significant maps’, which list terms in decreasing
order of the standard deviation of the –log (p-value) between the two comparisons. (d) Comparison of the relative expression of known
chicken ISGs between B cells infected with D78 (blue) and UK661 (orange).
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PKR, TRIM25, IRF7, PMAIP1, LGP2, DDX60 and PML),
TGFb signalling (DACT2, PML), inflammation (CCL4,
CCL5) and apoptosis (PMAIP1, PML). Previous reports
have also shown that members of several virus families
modulate HSP25 expression in a variety of cell types, sug-
gesting it has a broad role [25].
Enrichment analysis was performed using MetaCore (Clari-
vate) by matching differentially regulated genes in func-
tional Gene Ontologies (GO) and biological processes. The
probability of a random intersection between a set of genes
with ontology processes was estimated with the p-value of
the hypergeometric intersection (See Figs S2–S4 for a more
detailed analysis). The top GO processes (according to
MetaCore) were ‘defence response to virus’ and ‘immune
system processes’ (Fig. 4c). Taken together, these data show
that, following IBDV infection, cells launch a type I IFN
response characterized by the induction of ISGs, but that
the response is more marked following D78 infection than
UK661 infection. One limitation of the enrichment analysis
is that it relies on a comparison with mammalian gene
counterparts. Previously, we have defined chicken ISGs
using DNA microarrays and RNA sequencing in CEFs stim-
ulated with recombinant chicken IFNa [26], and we have
made the full list of chicken ISGs publicly available at http://
cisbic.bioinformatics.ic.ac.uk/skinner. To confirm and
extend the enrichment analysis observations, we compared
the relative expression of known chicken ISGs between cells
infected with the two virus strains. While the core set of
virus-induced genes was similar, the magnitude of the
change in gene expression was lower in cells infected with
UK661 than in those infected with D78. Moreover, RSAD2,
TGM2 and DDX60 were not induced by UK661 infection
(Fig. 4d).
Confirmation of microarray data for selected genes
by real-time RT-PCR
The microarray results were validated by determining the
level of expression of a panel of genes (IFIT5, IFI6, OASL,
Mx1, RSAD2, IFIH1, IFNa and IFNb) by RTqPCR in cul-
tures infected with D78 or UK661 (Fig. 5). For this analysis,
the log10 of the fold changes by microarray and RTqPCR
wereplotted against one another and the Spearman rank
correlation calculated. The mean Spearman correlation
coefficient (Spearman’s ) of cDNA microarray versus
qPCR was 0.90. Therefore, the level of differential gene
expression detected by each platform was highly similar.
Taken together, our data show that chicken primary B cells,
cultured ex vivo in the presence of chCD40L, can support
Fig. 5. Validation of the microarray results by RTqPCR. The fold change values for a panel of innate immunity related genes (IFIT5,
IFI6, OASL, Mx1, RSAD2, IFIH1, IFNa and IFNb), as determined by microarray and RTqPCR, were normalized by log10 transformation
and plotted against one another for cultures infected with D78 (circles) and UK661 (squares). GraphPad Prism v7.0a was used to cal-
culate the mean Spearman correlation coefficient (r).
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the replication of cell culture-adapted and vv strains of
IBDV. We identified several genes involved in B-cell activa-
tion and signalling that were down-regulated following D78
infection, including TNFSF13B (the gene encoding BAFF),
CD72 and GRAP. The cells responded to the infection by
inducing a type I IFN response with the up-regulation of
ISGs; however, the magnitude of the response was consider-
ably lower in cells infected with the vv strain UK661 than in
those infected with the attenuated strain D78.
DISCUSSION
Despite decades of vaccination, IBDV continues to be
endemic worldwide and frequently ranks in the top five dis-
eases of poultry [3]. Vaccines fail to induce sterilizing
immunity, and vaccinated birds may continue to shed wild-
type strains and reassortant viruses that contain genome
segments from both vaccine and field strains [27, 28]. More-
over, antigenically variant viruses have emerged on several
occasions, necessitating the development of novel vaccines
[7, 8], and a pathotypic variant, the very virulent strain,
emerged in the late 1980s (apparently by reassortment) to
spread across the globe, often necessitating the use of less
attenuated vaccines [6, 9, 10]. Even in the absence of overt
clinical signs, immunosuppression caused by IBDV infec-
tion can be an underlying cause of increased susceptibility
to secondary infections, some of which can be zoonotic. For
example, pre-exposure of chickens to IBDV exacerbated the
pathology, persistence or shedding of Salmonella enteritidis,
Campylobacter jejuni and Escherichia coli [29–31], and a
recent case-control study in Pakistan identified a history of
IBDV infection in flocks as a significant risk factor associ-
ated with avian influenza virus (AIV) infection in chickens
[32]. Moreover, experimental inoculation with IBDV pro-
longed the shedding of a subsequent AIV challenge [33],
and it was possible to adapt a mallard H5N2 AIV to chick-
ens by serial passage in birds that had previously been inoc-
ulated with IBDV, but not in birds that lacked IBDV
exposure [34].
Improved control strategies are therefore needed and, in the
future, it may be possible to breed or engineer chickens that
are resistant to IBDV disease, immunosuppression or even
infection, but key scientific questions need to be answered
before progress can be made in these areas. IBDV has a pre-
ferred tropism for B cells, and it is crucial to develop a
greater understanding of the molecular interactions of
IBDV with this cell type. The majority of B cells are located
in the BF and in vivo studies have shown that, following
IBDV infection, there is an increase in the expression of
genes involved in pro-inflammatory cytokine responses,
type I IFN induction and signalling, as well as apoptosis in
the BF [12, 16, 17]. However, the BF is made up multiple
cell types and, following infection, there is an influx of
inflammatory cells and effector T cells into the organ. The
various cell populations differ in the profile of genes they
express – for example, elevated expression of CD3, IL-18R1
and iNOS has been attributed to an influx of T cells, NK
cells and macrophages, respectively [16]. It is therefore
difficult to interpret how the infected B cells respond to
IBDV. To address this, some research groups have charac-
terized the transcriptional response of cells infected with
IBDV in culture [35–39]. These studies have the advantage
of well-defined multiplicities of infection (MOIs) and time
points p.i., and as transcriptional responses are from one
cell population, they are not confounded by multiple
cell types found in vivo. However, until recently it was not
possible to culture chicken primary B cells ex vivo, so the
transcriptome has typically been characterized in either
fibroblast cells [35, 36, 39] or dendritic cells [37]. While
providing some insight into host cell–IBDV interactions, vv
IBDV strains will not replicate in fibroblast cells without
prior adaptation and, as infection of B cells is crucial to the
pathogenesis of IBDV, the relevance of the data should not
be over-interpreted. Only one study to date has character-
ized the transcriptional response of B cells to IBDV infec-
tion [38], but that study utilized an immortalized B-cell line
that had been transformed following infection with ALV
(DT40 cells), limiting the conclusions that can be made.
In this study, we describe the successful culture of chicken
primary B cells ex vivo in the presence of soluble chCD40L
and demonstrate that these cells can support the replication
of an attenuated strain and the prototypic vv strain of
IBDV. Our work complements that of Sebastien Soubies
et al. in the lab of Nicolas Eterradossi, who have recently
demonstrated that phorbol 12-myristate 13-acetate (PMA)-
stimulated B cells can also support IBDV replication [40].
Ex vivo models of IBDV infection allow virus–host cell
interactions to be studied in the relevant host cells, retaining
the advantages of in vivo studies without the limitations of
multiple cell types that might confound the data. Moreover,
the models permit the use of defined MOIs and time-points,
thus retaining the advantages of in vitro systems. We have
extended this work by describing, for the first time, the tran-
scriptional profile of chicken primary B cells infected with
IBDV. While the validity of the model in recapitulating in
vivo data should be evaluated experimentally, the gene
expression profile we have observed is consistent with that
reported in previous studies. Thus 35 of the genes that we
identified as being differentially expressed in D78-infected
cells compared to mock-infected cells were previously
reported as having been differentially expressed following
IBDV infection in vivo [12, 14–17]. Only one contradiction
was found: the GSN gene was found to be down-regulated
in our study, yet up-regulated in one in vivo study [17].
GSN encodes Gelsolin, which regulates actin assembly and
has also been associated with inhibiting apoptosis [41]. The
reason for this discrepancy is unknown; it could be because
our experiment characterized gene expression at 18 h p.i.,
whereas the in vivo study was conducted at 3 and 4 days p.i.
We demonstrated that IBDV infection led to the down-reg-
ulation of key genes involved in B-cell activation and signal-
ling, such as TNFSF13B, CD72 and GRAP. This is
consistent with previous in vivo studies that showed down-
regulation of TNFSF13B, CD72 and GRAP in bursal tissue
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following infection with IBDV strain F52/70 [16, 17], and
with an in vitro study that found CD72 to be down-regu-
lated following IBDV infection of DT40 cells [38].
TNFSF13B encodes the B-cell activating factor (BAFF),
which is essential for the survival of B cells. BAFF is a trans-
membrane protein that is readily cleaved to release a soluble
factor. There are three known receptors for BAFF that are
expressed on B cells in varying amounts related to the matu-
ration of the cell, and BAFF-induced signalling stimulates B
cells to undergo proliferation and counters apoptosis [42].
CD72 is a co-receptor on B cells, the expression of which is
enhanced by BAFF [43]. It contains two immunoreceptor
tyrosine-based inhibitory motifs (ITIMs), ITIM1 and
ITIM2, and studies have associated it with both positive and
negative signalling [44]. Ligation of CD72 has been shown
to induce the proliferation of both resting and activated B
cells, with positive signalling thought to be mediated via the
Grb2–Sos–Ras pathway [44]. Grb2 and the Grb2-related
adaptor protein (GRAP) are both members of the same
family of adapter proteins that couple signals from receptor
tyrosine kinases to the Ras pathway [45]. Moreover, in the
chicken DT40 B-cell line, the Grb2 protein has been shown
to interact with the ITIM2 motif of the avian CD72 homo-
logue, attenuating negative signals from the ITIM1
motif and thus permitting positive signalling [46]. We spec-
ulate that, as BAFF leads to the up-regulation of CD72,
which positively signals via Grb-2 like proteins, the combi-
nation of BAFF, CD72 and GRAP leads to B-cell activation
and proliferation. As all three proteins are down-regulated
following IBDV infection, it is tempting to conclude that
IBDV targets this pathway, thereby reducing B-cell activa-
tion and proliferation, and that this could contribute to the
immunosuppression observed during infection, although
this requires experimental confirmation.
We demonstrated that chicken primary B cells responded to
infection with D78 by up-regulating the expression of type I
IFN genes and ISGs. This is consistent with a study by Hui
et al., which characterized the gene expression of DF-1 cells
infected with the D78 strain [35]. Twenty-two of the genes
that we identified as being differentially expressed in D78-
infected chicken primary B cells were similarly differentially
expressed following D78 infection of DF-1 cells. Notably,
Hui et al. identified that D78 triggered an IFIT5-IRF1/3-
Viperin pathway in infected DF-1 cells [35]. In our study,
D78 infection also led to the significant up-regulation of
IFIT5, IRF1, IRF7 and RSAD2 (Viperin), suggesting that
this pathway is also triggered in chicken primary B cells
infected with D78. In contrast, this pathway did not appear
to be induced by infection with UK661.
We also found that B cells infected with the attenuated
strain of IBDV (D78) up-regulated the expression of genes
involved in the innate immune response to a significantly
greater extent than cells infected with the vv strain
(UK661). Previous work using RTqPCR also showed the
expression of type I IFNa and b to be significantly lower in
BF tissue taken from birds infected with UK661 than with a
classical strain, F52-70 [47]. However, the authors studied
each virus in separate experiments and inoculated birds
with different titres of the two strains, limiting the conclu-
sions that could be made. In contrast, we characterized
responses in cells infected concurrently with the same MOI
of the two strains. Moreover, we found that IFNb expres-
sion was significantly reduced in cells infected with UK661
compared to mock-infected cells. This suggests that UK661
is not only able to inhibit the up-regulation of type I IFN,
but might actually suppress its induction. Taken together,
our results imply that UK661 is able to inhibit the up-regu-
lation of antiviral responses to a greater extent than D78,
which we speculate could contribute to its enhanced viru-
lence. It is also notable that the variance between like sam-
ples, demonstrated in the PCA plots (Fig. S1), appears lower
in UK661-infected than in mock- or D78-infected samples.
While we have not analysed the nature of this variance
directly and it might, in part, reflect technical variation, it
would also be consistent with UK661 exerting strict control
on gene expression in the infected cell, stricter indeed than
that exerted by D78.
One possible explanation for our observations is that
UK661 causes a global host transcriptional shut-off follow-
ing infection. However, the microarray demonstrates this is
not the case. Moreover, there was no significant difference
in the expression of the housekeeping gene TBP following
infection by RTqPCR (data not shown). Therefore, rather
than causing a global down-regulation of gene expression,
we believe the UK661 virus is able to inhibit pathways that
lead to the induction of Type I IFN responses to a greater
extent than D78. To date, two components of IBDV, VP3
and VP4, have been implicated in the suppression of innate
immune responses to IBDV infection. The VP3 protein
binds the viral double-stranded (ds) RNA genome and is
thought to block the interaction of MDA5 with the dsRNA,
thereby inhibiting downstream events that culminate in
type I IFN production [48]. In addition, the VP4 protein
binds to the cellular glucocorticoid-induced leucine zipper
(GILZ) protein, which inhibits the activation of nuclear fac-
tor kappa-enhancing binding (NF-KB) protein and activator
protein-1 (AP-1) [49]. In mammalian cells, NF-KB and AP-
1 cooperate with interferon regulatory factors (IRFs) 3 and
7 to stimulate type I IFN transcription. IBDV VP4 may
therefore inhibit type I IFN responses via binding to and
enhancing the inhibitory action of GILZ [49]. It is possible
that differences in the sequences of these viral proteins
between D78 and UK661 lead to differences in the antago-
nism of type I IFN induction.
In conclusion, the application of soluble chCD40L has
opened up the possibility of studying viral pathogenesis in
chicken primary B cells. Our data illustrate interesting dif-
ferences between how attenuated and very virulent strains
behave in infected B cells that could shed light on both the
molecular basis of IBDV-mediated immunosuppression,
and on the basis of the enhanced virulence of the vv strain.
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METHODS
Immortalized cell culture and virus
DT40 cells [50] were maintained in RPMI media supple-
mented with L-glutamine and sodium bicarbonate (Sigma-
Aldrich), 10% heat-inactivated fetal bovine serum (FBS)
(Sigma-Aldrich), tryptose phosphate broth (Sigma-Aldrich),
sodium pyruvate (Sigma-Aldrich) and 50mM beta-mercap-
toethanol (Gibco). HEK-293T cells stably expressing a solu-
ble chicken CD40L construct, msCD8-CD40L [18], were
cultured in RPMI supplemented with L-glutamine, sodium
bicarbonate, 10% heat-inactivated FBS and 1 ugml 1 puro-
mycin (Gibco). Immortalized cells were cultured at 37

C
and 5% CO2. A cell culture-adapted attenuated strain, D78
[8], and a vv strain, UK661 [9, 10], of IBDV were kind gifts
from Dr Nicolas Eterradossi, ANSES, France.
Virus titration
Ten-fold serial dilutions of D78 and UK661 viruses were
added to DT40 cells in 96-well plates and incubated for
3 days, whereupon cultures were fixed with 4% paraformal-
dehyde and labelled with a mouse monoclonal antibody
against IBDV VP2 (clone JF7-PD5; Kim Wark PhD thesis,
[51]; M. A. Skinner, unpublished) and a goat anti-mouse
monoclonal antibody conjugated to Alexa Fluor 488
(Thermo Fisher Scientific). Cultures were scored as positive
or negative based on the presence or absence of green fluo-
rescent cells, and the dilution at which 50% of the cells were
infected (the tissue culture infectious dose 50, TCID50) was
computed using the method described by Reed and Muench
[52].
CD40L stock production
Supernatant was harvested from HEK-293T cells stably
expressing the msCD8-CD40L construct (chicken (ch)
CD40L) and concentrated using Pierce Protein Concentra-
tors PES (Thermo Fisher Scientific) according to the
manufacturer’s instructions. Concentrated chCD40L was
filter-sterilized using a 0.22 µM Millex-GP Syringe Filter
(Merck), stored at 4

C and titrated prior to use. Briefly, pri-
mary B cells were cultured in the presence of two-fold serial
dilutions of chCD40L for up to 6 days. Each day, the num-
ber and viability of the cells was determined by Trypan Blue
(Sigma-Aldrich) exclusion, and the chCD40L dilution
which gave the most favourable number and viability was
selected for use (1 : 40).
Chickens
Embryonated eggs of the Rhode Island Red line were pro-
vided by the National Avian Research Facility (NARF).
Chickens were hatched and housed in specific pathogen-
free (SPF) facilities at The Pirbright Institute and reared
until 3 weeks of age, whereupon they were humanely culled
by a Schedule 1 procedure. All procedures were performed
in accordance with the UK Animal (Scientific Procedures)
Act 1986 under Home Office Establishment, Personal and
Project licences, after the approval of the internal Animal
Welfare and Ethical Review Board (AWERB).
Chicken primary B cell culture
The bursa of Fabricius was harvested aseptically post-mor-
tem and washed in sterile PBS. An enzyme solution contain-
ing 2.2mgml 1 collagenase D (Sigma-Aldrich) in Hanks
balanced salt solution supplemented with calcium (Gibco)
and 7.5% sodium carbonate was used to digest the bursal
tissue. Once digested, the tissue was passed through a
100 µM Falcon cell strainer (Thermo Fisher Scientific) into
cell medium containing Hanks balanced salt solution
(Gibco) supplemented with 7.5% sodium carbonate and
500mM EDTA (Sigma-Aldrich), before pelleting. Cells
were resuspended in Iscove’s modified Dulbecco’s medium
(IMDM) supplemented with FBS, chicken serum (Sigma-
Aldrich), insulin transferrin selenium (Gibco), beta-mercap-
toethanol (Gibco) and penicillin/streptomycin and nystatin
(B-cell media; as described by [19]), before undergoing cen-
trifugation at 2000 r.p.m. for 20min at 4

C over Histopaque
1083 (Sigma-Aldrich). Bursal cells that banded at the inter-
face of the medium and histopaque were collected, washed
in PBS and counted using the TC20 Automated Cell
Counter (Bio-Rad). Cells were seeded in 24-well plates at
1107 cells per ml and maintained at 37

C in 5% CO2 in
B-cell media supplemented with chCD40L.
Virus inoculation
Chicken primary B cells were infected with the attenuated
strain D78 and the vv strain UK661 at a MOI of 3, after
which cells were washed with media and cultured in B-cell
media supplemented with chCD40L. Following incubation
at 37

C with 5% CO2 for the indicated amount of time, a
100 µl sample of each well was obtained for processing for
bio-imaging. The remaining cells were washed in PBS,





Cells were pelleted, washed in PBS and fixed in 4% parafor-
maldehyde (Sigma-Aldrich) for 1 h at room temperature.
Cells were permeabilized using 0.5% Triton X-100 (Sigma-
Aldrich) for 30min at room temperature, blocked with 4%
bovine serum albumin (Sigma-Aldrich) for 30min at room
temperature on a rotating platform and then labelled with a
primary mouse monoclonal antibody against the IBDV VP2
protein (clone JF7-PD5) and incubated for 1 h at room tem-
perature. After washing in PBS, the cells were incubated for
1 h with a goat anti-mouse secondary monoclonal antibody
conjugated to Alexa Fluor 488 (Thermo Fisher Scientific).
Cells were counterstained with DAPI (Sigma-Aldrich) and
adhered to glass coverslips (TAAB, Aldermaston, UK) that
had been coated with CellTak (Fisher Scientific) by centrifu-
gation. Coverslips were mounted onto glass slides and
stained cells were viewed with a Leica SP5 confocal
microscope.
Nucleic acid extraction
Total RNA was extracted from mock-infected and IBDV-
infected B cells using an RNeasy kit (Qiagen) according to
the manufacturer’s instructions. On-column DNA digestion
Dulwich et al., Journal of General Virology 2017;98:2918–2930
2927
was performed using RNase-free DNase (Qiagen) to remove
contaminating genomic DNA. RNA samples were quanti-
fied using a Nanodrop Spectrophotometer (Thermo Scien-
tific) and checked for quality using a 2100 Bioanalyzer
(Agilent Technologies). All RNA samples had an RNA
integrity number (RIN) 9.6. RNA samples were halved
and processed for either microarray or RTqPCR.
Quantification of virus replication by RTqPCR
Reverse transcription of RNA samples was performed using
SuperScript III Reverse Transcriptase (Thermo Fisher Scien-
tific). The cDNA was synthesized according to the manufac-
turer’s instructions. Forward and reverse primers and a
Taqman probe (Table S1) targeting a conserved region of
the IBDV VP4 sequence (Sigma-Aldrich) were used to
amplify the template. Briefly, the template, primers and
probe were added to a Taqman Universal PCR Master Mix
(Applied Biosystems) and reactions were performed on
a 7500 Fast Real-Time PCR system (Life Technologies)
using the following cycling conditions: 95

C for 10min; 40
cycles of 95

C for 15 s; 60

C for 1min; 95






C for 30 s; 60

C for 15 s. All target gene
expression levels were normalized to the housekeeping gene
TBP and compared to the mock controls using the compar-




For the microarray study the GeneChip 3’ IVT Express Kit
(Affymetrix) was used, following the manufacturer’s
instructions. Hybridization of RNA to chips and scanning
of arrays was performed by the Medical Research Council’s
Clinical Sciences Centre (CSC) Genomics Laboratory, Ham-
mersmith Hospital, London, UK. RNA was hybridized to
GeneChip Chicken Genome Array chips (Affymetrix) in a
GeneChip Hybridization Oven (Affymetrix); the chips were
stained and washed on a GeneChip Fluidics Station 450
(Affymetrix), and the arrays were scanned in a GeneChip
Scanner 3000 7G with autoloader (Affymetrix).
Nucleic acid labelling
Biotinylated fragmented RNA was prepared for each sample
using standard procedures in the GeneChip 3¢ IVT Express
Kit user’s manual.
Nucleic acid hybridization to array
Array hybridization was performed according to the manu-
facturer’s instructions (Affymetrix). Labelled samples were
hybridized to the GeneChip Chicken Genome Arrays (Affy-
metrix Inc.) in a GeneChip Hybridization Oven for 16 h at
45

C and 60 r.p.m. in an Affymetrix Hybridization Oven
645.
Array scanning and feature extraction protocol
After washing and staining, the arrays were scanned with
the Affymetrix GeneChip Scanner 3000 7G. Gene-level
expression signal estimates were derived from CEL files gen-
erated from raw data using the multi-array analysis (RMA)
algorithm implemented from the Affymetrix GeneChip
Command Console Software Version 3.0.1.
Normalization data transformation protocol
Data pre-processing and filtering was done using the Partek
Genomics Suite software, v.6.6 and included: RMA back-
ground correction, quantile normalization across all chips
in the experiment, log2 transformation and median polish
summarization.
Microarray data analysis
A one-way ANOVA (variable: treatment) adjusted with the
Benjamini–Hochberg multiple-testing correction [false dis-
covery rate (FDR) of P<0.05] was performed with Partek
Genomics Suite (v6.6, Partek) across all samples. Principal
component analysis (PCA), which shows sample variability
in three-dimensional space, confirmed the lack of variability
among infected samples (Fig. S1). Comparisons were con-
ducted between B-cells infected with D78 and UK661 versus
mock-treated cells and between cells infected with D78 versus
cells infected with UK661. The analysis cut-off criteria were
fold change ±1.5 and P-value0.05. The Affymetrix
chicken genome arrays contain probe sets for detecting tran-
scripts from 17 avian viruses, including IBDV, allowing con-
firmation of viral infection. The full results of the microarray
analysis are listed in Tables S2–S4. According to the MIAME
guidelines, the original microarray data produced in this
study have been deposited in the public database ArrayEx-
press (http://www.ebi.ac.uk/microarray-as/ae/), with the
accession number E-MTAB-5947.
Data mining and enrichment analysis was performed using
the MetaCore software suite (Clarivate Analytics, https://
clarivate.com/products/metacore/). Enrichment analysis
consisted of mapping gene IDs of the datasets onto gene
IDs of human orthologues in entities of built-in functional
ontologies represented in MetaCore by pathway maps and
process networks. Statistical significance was measured by
the number of genes that map onto a given pathway and
was calculated on the basis of p-value, based on hypergeo-
metric distribution (a built-in feature of MetaCore). Enrich-
ment analysis for the mock-infected Vs D78, mock-infected
Vs UK661 and D78 Vs UK661 datasets is presented in Figs
S2–S4.
Microarray validation
RTqPCR was performed on RNA samples using a two-step
procedure. RNA was first reverse-transcribed into cDNA
using the QuantiTect Reverse Transcription Kit (Qiagen)
according to the manufacturer’s instructions. qPCR was
then conducted on the cDNA in a 384-well plate with a
ABI-7900HT Fast qPCR system (Applied Biosystems).
Mesa Green qPCR MasterMix (Eurogentec) was added to
the cDNA (5 µl for every 2 µl of cDNA). The following
amplification conditions were used: 95

C for 5min; 40
cycles of 95

C for 15 s, 57

C for 20 s and 72

C for 20 s;
95

C for 15 s; 60

C for 15 s; and 95

C for 15 s. Primer
sequences for genes that were used in the study are given in
Table S1. The output Ct values and dissociation curves were
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analysed using SDS v2.3 and RQ Manager v1.2 (Applied
Biosystems). Gene expression data were normalized against
the housekeeping gene GAPDH, and compared to the mock
controls using the 2–DDCT method [53]. All samples were
loaded in triplicate.
STATISTICS
Statistical significance of the average number of live cells
and percentage viability was determined by an unpaired
two-tailed Student’s t-test (Graphpad Prism, version 7;
Fig. 1). For RTqPCR data, the Ct values of the gene in ques-
tion were normalized to the Ct values of a housekeeping
gene as per the 2– DCt method [53] and subsequently passed
a Shapiro– Wilk normality test before being analysed using
2-way ANOVA and Tukey’s multiple comparison test
(Graphpad Prism, version 7). Graphs of the 2–DCt are
included (Fig. S5). Data were subsequently normalized to
mock controls according to the 2–DDCt method and fold
changes plotted (Figs 2 and 3). For the microarray, a one-
way ANOVA (variable: treatment) adjusted with the Benja-
mini–Hochberg multiple-testing correction (false discovery
rate (FDR) of P<0.05) was performed with Partek Genomics
Suite (v6.6, Partek) across all samples. For gene enrichment
analyses, significance was determined using MetaCore ver-
sion 6.31 build 68 930 (*P<0.05, **P<0.01, ***P<0.001,
****P<0.0001).
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